The World Health Organization (WHO) data on HIV/AIDS for 2018 is 37.9 million people living with HIV/AIDS worldwide and 770 000 deaths due to HIV-related illnesses worldwide. There is insufficient information about the cost-effectiveness of therapy in HIV<unk><unk> .
HIV associated nephropathy cost-effectiveness of therapy
HIV AIDS cost-effectiveness of therapy
Hepatitis B cost-effectiveness of therapy
Hepatitis C cost-effectiveness of therapy
Leprosy cost-effectiveness of therapy
Hepatitis D cost-effectiveness of therapy
Tuberculosis cost-effectiveness of therapy
HIV AIDS future or investigational therapies